Surrozen, Inc.
NASDAQ:SRZNBiotechnology
Healthcare
$30.67 -4.74%
-$1.14 today
- Market cap
- $229.33M
- Beta
- 0.51
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$31.29
52W Low $8.00High $35.00
Volume 0.09M
Average 0.11M
Income Statement
Follow revenue through to earnings.
Revenue
$3.48M
FY 2025 · Annual
-67.4% YoYOperating Income
-$42.09M
FY 2025 · Annual
Net Income
-$242.03M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 12.5M | 0 | 10.66M | 3.48M |
| Cost of Revenue | 3.3M | 3.27M | 27.23M | 0 | 537K |
| Gross Profit | (3.3M) | 9.23M | (27.23M) | 10.66M | 2.94M |
| Gross Margin | — | 73.8% | — | 100.0% | 84.6% |
| Research & Development | 36.88M | 37.01M | 27.23M | 21.13M | 29.37M |
| Selling, General & Admin | 14.21M | 19.83M | 15.8M | 15.06M | 16.2M |
| Operating Expenses | 51.09M | 53.57M | 18.55M | 36.19M | 45.03M |
| Depreciation & Amortization | 3.3M | 1.96M | 1.91M | 1.44M | 537K |
| EBITDA | (51.35M) | (34.05M) | (41.13M) | (62.12M) | (241.49M) |
| EBITDA Margin | — | -272.4% | — | -583.0% | -6945.3% |
| Operating Income | (54.39M) | (44.34M) | (45.78M) | (25.54M) | (42.09M) |
| Operating Margin | — | -354.7% | — | -239.7% | -1210.6% |
| Interest Income | 72K | 781K | 2.34M | 1.69M | 3.02M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (257K) | 8.34M | 2.74M | (38.03M) | (199.93M) |
| Income Before Tax | (54.65M) | (36M) | (43.04M) | (63.56M) | (242.03M) |
| Pre-Tax Margin | — | -288.0% | — | -596.6% | -6960.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (52.51M) | (36M) | (43.04M) | (63.56M) | (242.03M) |
| Net Margin | — | -288.0% | — | -596.6% | -6960.8% |
| EPS (Basic) | (23.40) | (15.55) | (21.33) | (21.67) | (32.37) |
| EPS (Diluted) | (23.40) | (15.55) | (21.33) | (21.67) | (32.37) |
| 2.34M | 2.31M | 2.02M | 2.93M | 7.48M | |
| 2.34M | 2.31M | 2.02M | 2.93M | 7.48M |
SRZN Earnings Waterfall · TTM
NASDAQ:SRZN · Revenue to Net Income
Key Ratios
EPS$-41.33
Gross Margin99.7%
Net Margin-10121.0%
P/E Ratio-0.2
P/S Ratio160.8
Analysis
$7.5M of revenue converted into -$342.6M of net income for the selected period. Gross margin is 99.7% and net margin is -10121.0%, showing how much revenue survives after costs and taxes. EPS is $-41.33, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| FWP | FWP filing | Nov 13, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| SC 13D/A | SC 13D/A filing | Nov 6, 2026 |
How much revenue does SRZN generate?
Surrozen, Inc. (SRZN) reported $3.48M of revenue in fiscal 2025.
Is SRZN profitable?
Surrozen, Inc. (SRZN) reported -$242.03M of net income, with a net margin of -6960.8%.
Continue the stock analysis
Jump to another research area for this company.